AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $368,000 | -66.5% | 513,292 | +5.6% | 0.02% | -61.5% |
Q4 2021 | $1,099,000 | -32.6% | 486,220 | -14.1% | 0.04% | -35.0% |
Q3 2021 | $1,630,000 | -22.2% | 566,026 | +2.4% | 0.06% | -20.0% |
Q2 2021 | $2,096,000 | +7.2% | 552,976 | -4.3% | 0.08% | +17.2% |
Q1 2021 | $1,956,000 | -54.8% | 577,972 | -62.6% | 0.06% | -57.9% |
Q4 2020 | $4,329,000 | +9.2% | 1,546,169 | -2.1% | 0.15% | -5.0% |
Q3 2020 | $3,963,000 | -78.7% | 1,579,079 | +15.0% | 0.16% | -80.0% |
Q2 2020 | $18,644,000 | +74.8% | 1,372,888 | -2.4% | 0.80% | +34.2% |
Q1 2020 | $10,666,000 | +20.7% | 1,407,164 | +0.6% | 0.60% | +99.3% |
Q4 2019 | $8,839,000 | +51.9% | 1,398,621 | -5.8% | 0.30% | +43.8% |
Q3 2019 | $5,818,000 | -19.5% | 1,484,137 | -0.7% | 0.21% | -13.3% |
Q2 2019 | $7,231,000 | -42.9% | 1,494,070 | -3.3% | 0.24% | -41.2% |
Q1 2019 | $12,659,000 | +87.4% | 1,545,682 | +26.5% | 0.41% | +65.9% |
Q4 2018 | $6,755,000 | +1802.8% | 1,221,498 | +2937.0% | 0.25% | +1792.3% |
Q3 2018 | $355,000 | – | 40,220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |